ROCKVILLE, Md., April 30, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal ...
SEATTLE--(BUSINESS WIRE)--Proniras Corporation (“Proniras”), a clinical-stage biotechnology company developing novel small-molecule therapeutics for the treatment of substance use and specialty ...
Atul Saran, a senior vice president of the biotechnology company MedImmune, planned to "churn through" eight to 12 meetings a day during the BIO convention in Boston, which ends its four-day run on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback